Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-06-21 16:31:02
Reporting Period:
Filing Date:
Accepted Time:
2011-06-21 16:31:02
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1453814 Medidata Solutions Inc. MDSO Services-Prepackaged Software (7372) 522319066
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237855 D Bruce Dalziel C/o Medidata Solutions, Inc.
79 Fifth Avenue, 8Th Floor
New York NY 10003
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-17 12,000 $12.08 89,391 No 4 M Direct
Common Stock Disposition 2011-06-17 12,000 $21.63 77,391 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-05-17 12,000 $0.00 12,000 $12.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
173,000 2017-10-02 No 4 M Direct
  1. The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2011.
  2. Such transaction was executed in multiple trades at prices ranging from $21.30 to $21.80. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. These options vested and become exercisable as to 25% of the underlying shares on September 10, 2008 and the remaining vest ratably each month over three years thereafter.